Apple Inc.'s closely watched moves into the health-care sector in recent years has finally resulted in an US FDA-approved product. The tech giant announced Sept. 12 it gained de novo classifications for an electrocardiogram functions and software that will be embedded in the latest Apple Watch.
After several years of skepticism, big tech companies such as Apple, Google and others have been making inroads in recent years with FDA and this approval may be a big sign of a progress